ArticleJournal of clinical medicine2026

Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease.

Alessandra Saraga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.